Chad Dalton is a Director at Merck, where they lead strategic and technical initiatives in clinical supply management since 2023, following a tenure that began in 2015. Previously, they served as a Principal Scientist, overseeing complex drug development projects and contributing to key initiatives focused on formulation and quality assurance. Chad's career at Merck Frosst Canada included roles as a Senior Research Chemist, where they guided the development of new compounds from preclinical stages to proof of concept. They hold a BSc in Chemistry from Concordia University and a DEC in Pure & Applied Science from Dawson College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices